Noninvasive assessment of pediatric inflammatory bowel disease with 18F-fluorodeoxyglucose-positron emission tomography and computed tomography

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 1, 2011, Pages 81-89

  Däbritz, Jan ^a   Jasper, Niklas ^a   Loeffler, Markus ^a   Weckesser, Matthias ^a   Foell, Dirk ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

computed tomography; Crohn's disease; fluorodeoxyglucose positron emission tomography; inflammatory bowel disease; pediatric; ulcerative colitis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MESALAZINE; METHOTREXATE; STEROID;

ADOLESCENT; ARTICLE; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ECHOGRAPHY; ENDOSCOPY; ENTERITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 78650766318     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283410222     Document Type: Article

References (31)

1. Bernstein CN, Shanahan F. Disorders of a modern lifestyle: Reconciling the epidemiology of inflammatory bowel diseases. Gut 2008; 57:1185-1191.
2. Rufo PA, Bousvaros A. Challenges and progress in pediatric inflammatory bowel disease. Curr Opin Gastroenterol 2007; 23:406-412. (Pubitemid 46878953)
3. Löffler M, Weckesser M, Franzius C, Schober O, Zimmer KP. High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann N Y Acad Sci 2006; 1072:379-385.
4. MacKalski BA, Bernstein CN. New diagnostic imaging tools for inflammatory bowel disease. Gut 2006; 55:733-741.
5. Lemberg DA, Issenman RM, Cawdron R, Green T, Mernagh J, Skehan SJ, et al. Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis 2005; 11:733-738.
6. Bicik I, Bauerfeind P, Breitbach T, von Schulthess GK, Fried M. Inflammatory bowel disease activity measured by positron-emission tomography. Lancet 1997; 350:262.
7. Neurath MF, Vehling D, Schunk K, Holtmann M, Brockmann H, Helisch A, et al. Noninvasive assessment of Crohn's disease activity: A comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol 2002; 97:1978-1985.
8. Kresnik E, Gallowitsch HJ, Mikosch P, Würtz F, Alberer D, Hebenstreit A, et al. (18)F-FDG positron emission tomography in the early diagnosis of enterocolitis: Preliminary results. Eur J Nucl Med Mol Imaging 2002; 29:1389-1392.
9. Skehan SJ, Issenman R, Mernagh J, Nahmias C, Jacobson K. 18Ffluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease. Lancet 1999; 354:836-837.
10. Jasper N, Däbritz J, Wittkowski H, Weckesser M, Foell D. Diagnostic value of FDG-PET and PET-CT in pediatric patients with chronic IBD. Gastroenterology 2008; 134 (Suppl 1):199.
11. Däbritz J, Jasper N, Loeffler M, Foell D. Segment-based evaluation of 18F-FDG-PET ± CT in the assessment of pediatric IBD. Gastroenterology 2009; 136 (Suppl 1):643.
12. Louis E, Ancion G, Colard A, Spote V, Belaiche J, Hustinx R. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT. J Nucl Med 2007; 48:1053-1059.
13. Lapp RT, Spier BJ, Perlman SB, Jaskowiak CJ, Reichelderfer M. Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease. Mol Imaging Biol 2010 [Epub ahead of print].
14. Spier BJ, Perlman SB, Jaskowiak CJ, Reichelderfer M. PET/CT in the evaluation of inflammatory bowel disease: Studies in patients before and after treatment. Mol Imaging Biol 2010; 12:85-88.
15. Spier BJ, Perlman SB, Reichelderfer M. FDG-PET in inflammatory bowel disease. Q J Nucl Med Mol Imaging 2009; 53:64-71.
16. Meisner RS, Spier BJ, Einarsson S, Roberson EN, Perlman SB, Bianco JA, et al. Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis 2007; 13:993-1000.
17. Halpenny DF, Burke JP, Lawlor GO, O'Connell M. Role of PET and combination PET/CT in the evaluation of patients with inflammatory bowel disease. Inflamm Bowel Dis 2009; 15:951-958.
18. Lebiedz P, Maaser C, Fanzius C,Wessling J, Lugering A, Heidemann J, et al. PET-CT - a new diagnostic tool for differentiation between inflammatory and fibromatous stenosis in Crohn's disease? Gastroenterology 2005; 128 (Suppl 2):A-310.
19. Daperno M, D'Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: The SES-CD. Gastrointest Endosc 2004; 60:505-512.
20. Lassmann M, Biassoni L, Monsieurs M, Franzius C, Jacobs F. The new EANM paediatric dosage card. Eur J Nucl Med Mol Imaging 2007; 34:796-798.
21. Jacobs F, Thierens H, Piepsz A, Bacher K, Van de Wiele C, Ham H, Dierckx RA. Optimised tracer-dependent dosage cards to obtain weight-independent effective doses. Eur J Nucl Med Mol Imaging 2005; 32:581-588.
22. Franzius C, Juergens KU, Schober O. Is PET/CT necessary in paediatric oncology? Eur J Nucl Med Mol Imaging 2006; 33:960-965.
23. Gerth HU, Juergens KU, Dirksen U, Gerss J, Schober O, Franzius C. Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors. J Nucl Med 2007; 48:1932-1939.
24. Stabin MG, Gelfand MJ. Dosimetry of pediatric nuclear medicine procedures. Q J Nucl Med 1998; 42:93-112.
25. Stamm G, Nagel HD. CT-expo - a novel program for dose evaluation in CT. Rofo 2002; 174:1570-1576.
26. Yasuda S, Takahashi W, Takagi S, Fujii H, Ide M, Shohtsu A. Factors influencing physiological FDG uptake in the intestine. Tokai J Exp Clin Med 1998; 23:241-244.
27. Kim S, Chung JK, Kim BT, Kim SJ, Jeong JM, Lee DS, Lee MC. Relationship between gastrointestinal F-18-fluorodeoxyglucose accumulation and gastrointestinal symptoms in whole-body PET. Clin Positron Imaging 1999; 2:273-279.
28. Meyer MA. Diffusely increased colonic F-18 FDG uptake in acute enterocolitis. Clin Nucl Med 1995; 20:434-435.
29. Hannah A, Scott AM, Akhurst T, Berlangieri S, Bishop J, McKay WJ. Abnormal colonic accumulation of fluorine-18-FDG in pseudomembranous colitis. J Nucl Med 1996; 37:1683-1685.
30. Kresnik E, Mikosch P, Gallowitsch HJ, Heinisch M, Lind P. F-18 fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory bowel disease. Clin Nucl Med 2001; 26:867.
31. Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: Meta-analysis of prospective studies. Radiology 2008; 247:64-79.